Table 4.
Bivariate analysis of disease specific factors and co-morbidities of multidrug-resistant (MDR) and drug susceptible (DS) tuberculosis respondents
| Variable | MDR-TBa (N = 31) No (%) | DS-TBb (N = 93) No (%) | OR (95% CI) | p value according to ULRA |
|---|---|---|---|---|
| Previous TB treatment history | 16 (51.6) | 28 (30.1) | 2.65 (1.14–6.16) | 0.023 |
| Default from treatment | 10 (32.2) | 11 (11.8) | 3.84 (1.41–11.11) | 0.008 |
| Hypertension | 6 (19.4) | 16 (17.2) | 1.15 (0.40–3.27) | 0.786 |
| COPDc | 6 (19.4) | 4 (4.3) | 5.34 (1.39–20.40) | 0.014 |
| Diabetes | 3 (9.7) | 10 (10.8) | 0.89 (0.22–3.46) | 0.866 |
| Depression and anxiety | 3 (9.7) | 3 (3.22) | 3.21 (0.61–16.83) | 0.167 |
| All co-morbiditiesd | 12 (38.7) | 27 (39.0) | 0.65(0.28–1.52) | 0.317 |
| Experience of hospital stay over the lifetime | 16 (51.6) | 28 (30.1) | 2.47 (1.08–5.69) | 0.033 |
| Experience of being in a congregate setting over the lifetime | 6 (19.4) | 12 (12.9) | 0.62 (0.21–1.81) | 0.381 |
| Seeking help related to TB in public health care institution | 29 (93.5) | 80 (86.0) | 2.35 (0.51–11.08) | 0.278 |
aPatients resistant to isoniazid and rifampicin (with or without resistance to additional anti-TB drugs); bPatients infected with drug susceptible M. tuberculosis strain; cChronic obstructive pulmonary disease; dHypertension, COPD, diabetes and depression